The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of UiPath Inc (NYSE: PATH) closed at $15.87 in the last session, down -2.10% from day before closing price of $16.21. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 15.14 million shares were traded. PATH stock price reached its highest trading level at $16.325 during the session, while it also had its lowest trading level at $15.41.
Ratios:
We take a closer look at PATH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.22. For the most recent quarter (mrq), Quick Ratio is recorded 2.63 and its Current Ratio is at 2.63. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on October 02, 2025, Reiterated its Market Perform rating but revised its target price to $13 from $12.50 previously.
BMO Capital Markets reiterated its Market Perform rating for the stock on September 05, 2025, while the target price for the stock was revised from $15.50 to $12.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 30 ’25 when Dines Daniel sold 45,000 shares for $15.73 per share. The transaction valued at 707,643 led to the insider holds 29,468,585 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $772,344 on Oct 28 ’25. The CEO and Chairman now owns 29,558,585 shares after completing the transaction at $17.16 per share. On Oct 27 ’25, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $16.73 each. As a result, the insider received 752,670 and left with 29,603,585 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 8427313152 and an Enterprise Value of 7059136512. As of this moment, UiPath’s Price-to-Earnings (P/E) ratio for their current fiscal year is 444.54, and their Forward P/E ratio for the next fiscal year is 21.40. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 29.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.63 while its Price-to-Book (P/B) ratio in mrq is 5.06. Its current Enterprise Value per Revenue stands at 4.717 whereas that against EBITDA is -415.268.
Stock Price History:
The Beta on a monthly basis for PATH is 1.11, which has changed by 0.26252985 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $18.74, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is 17.94%, while the 200-Day Moving Average is calculated to be 26.33%.
Shares Statistics:
According to the various share statistics, PATH traded on average about 21.00M shares per day over the past 3-months and 23289640 shares per day over the past 10 days. A total of 453.40M shares are outstanding, with a floating share count of 406.53M. Insiders hold about 23.44% of the company’s shares, while institutions hold 64.19% stake in the company. Shares short for PATH as of 1760486400 were 48050582 with a Short Ratio of 2.29, compared to 1757894400 on 52288268. Therefore, it implies a Short% of Shares Outstanding of 48050582 and a Short% of Float of 13.350001.
Earnings Estimates
Currently, 19.0 analysts are dedicated to thoroughly evaluating and rating the performance of UiPath Inc (PATH) in the stock market.The consensus estimate for the next quarter is $0.26, with high estimates of $0.29 and low estimates of $0.23.
Analysts are recommending an EPS of between $0.71 and $0.62 for the fiscal current year, implying an average EPS of $0.66. EPS for the following year is $0.74, with 20.0 analysts recommending between $0.85 and $0.57.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $392.46M. It ranges from a high estimate of $393.7M to a low estimate of $389M. As of. The current estimate, UiPath Inc’s year-ago sales were $354.65MFor the next quarter, 17 analysts are estimating revenue of $462.69M. There is a high estimate of $465.6M for the next quarter, whereas the lowest estimate is $459M.
A total of 18 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.58B, while the lowest revenue estimate was $1.57B, resulting in an average revenue estimate of $1.57B. In the same quarter a year ago, actual revenue was $1.43BBased on 19 analysts’ estimates, the company’s revenue will be $1.71B in the next fiscal year. The high estimate is $1.76B and the low estimate is $1.66B.
